Showing results (11-20 of 54) with videos related to
Sort By:
Pageof 6
Cancer|February 1, 1996
Cisplatin-based chemotherapy of primary extragonadal germ cell tumors. A single institution experienceA Gerl, C Clemm, R Lamerz, et al.Oncology Reports|May 25, 2011
Adjuvant chemotherapy of stage-ii nonseminomatous testicular cancerA Gerl, C Clemm, P Kohl, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Prognostic implications of tumour marker analysis in non-seminomatous germ cell tumours with poor prognosis metastatic diseaseA Gerl, C Clemm, R Lamerz, et al.Cancer|April 3, 2001
The impact of chemotherapy on Leydig cell function in long term survivors of germ cell tumorsA Gerl, D Mühlbayer, G Hansmann, et al.Acta Oncologica (Stockholm, Sweden)|January 1, 1993
Etoposide, cisplatin, bleomycin, and cyclophosphamide (ECBC) as first-line chemotherapy for poor-risk non-seminomatous germ cell tumorsA Gerl, C Clemm, M Hentrich, et al.Clinical & Experimental Metastasis|May 1, 1994
Central nervous system as sanctuary site of relapse in patients treated with chemotherapy for metastatic testicular cancerA Gerl, C Clemm, P Kohl, et al.Anticancer Research|July 1, 1997
Is serum tumor marker half-life a guide to prognosis in metastatic nonseminomatous germ cell tumors?A Gerl, R Lamerz, K Mann, et al.Medizinische Klinik (Munich, Germany : 1983)|May 15, 1994
[Primary extragonadal germ cell tumors. Clinical manifestations, differential diagnosis and therapy]A Gerl, C Clemm, P Kohl, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2010
Myocardial infarction and other major vascular events during chemotherapy for testicular cancerK-P Dieckmann, A Gerl, J Witt, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2002
High-dose versus conventional-dose chemotherapy as first-salvage treatment in patients with non-seminomatous germ-cell tumors: a matched-pair analysisJ Beyer, S Stenning, A Gerl, et al.Pageof 6